Regeneron

Regeneron is a leading biotechnology company inventing life-transforming medicines for people with serious diseases. Our medicines and pipeline aim to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare disorders.Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies (such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies) and ambitious research initiatives (such as the Regeneron Genetics Center®, which is conducting one of the largest genetic sequencing efforts in the world).